Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with Digibind: Stoichiometry and its implications

American Journal of Hypertension

Volumn 9, Issue 1, 1996, Pages 39-46

  Krep, Hans Henning ^a   Graves, Steven W ^a   Price, Deborah A ^a   Lazarus, Michael ^a   Ensign, Allison ^a   Soszynski, Piotr A ^a   Hollenberg, Norman K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Digibind; Digitalis like factor; Na,K ATPase; Ouabain; Rabbit aorta; Vascular smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; DIGOXIN ANTIBODY F(AB) FRAGMENT; OUABAIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTICLE; DRUG EFFECT; DRUG INHIBITION; HYPERTENSION; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RENOVASCULAR DISEASE; STOICHIOMETRY; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; DIGOXIN; ENZYME INHIBITORS; FEMALE; HUMANS; HYPERTENSION; IMMUNOGLOBULIN FAB FRAGMENTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NA(+)-K(+)-EXCHANGING ATPASE; OUABAIN; RABBITS;

EID: 0030027367     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00260-X     Document Type: Article

References (21)

1. Haddy FJ, Overbeck HW: The role of humoral agents in volume expanded hypertension. Life Sci 1976;19:935-948.
2. Blaustein MP: Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol 1977;232:C165-C173.
3. Goto A, Yamada K, Yagi N, et al: Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev 1992;44:377-399.
4. Buckalew VM, Jr., Haddy FJ: Circulating natriuretic factors in hypertension, in Brenner BM, Laragh JH (eds): Hypertension: Pathophysiology, Diagnosis, and Management. Raven Press, New York, 1990, Chapter 60, pp 939-954.
5. Wechter WJ, Benaksas EJ: Natriuretic hormones. Prog Drug Res 1990;34:232-260.
6. Hamlyn JM, Manunta P: Ouabain, digitalis-like factors and hypertension. J Hypertens 1992;10(suppl 7):99-111.
7. Graves SW: The sodium pump in hypertension. Curr Opinion Nephrol Hypertens 1994;3:107-111.
8. - ATPase. Comp Biochem Physiol 1993;105C: 1-9.
9. Woolfson RG, Poston L, De Wardener HE: Digoxin-like inhibitors of active sodium transport and blood pressure: the current status. Kidney Int 1994;46:297-309.
10. + to the contractile response. Circ Res 1993;73:1113-1120.
11. Graves SW, Glatter KA, Lazarus JM, et al: Volume expansion in renal failure patients: a paradigm for a clinically relevant [Na,K] ATPase Inhibitor. J Cardiovasc Pharmacol 1993;22sSuppl 2):S54-S57.
12. Glatter KA, Graves SW, Hollenberg NK, et al: Sustained volume expansion and [Na,K]ATPase inhibition in chronic renal failure. Am J Hypertens 1994;7:1016-1025.
13. Goodlin RC: Antidigoxin antibodies in eclampsia. N Engl J Med 1988;318:518-519.
14. Balzan S, Montali U, Biver P, Ghione S: Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes. J Hypertens 1991;9:304-305.
15. Harder DR: Membrane electrical activation of arterial smooth muscle, in Crass MF, Barnes CD (eds): Vascular Smooth Muscle: Metabolic, Ionic, and Contractile Mechanisms. Academic Press, Inc., London, 1982, Chapter 3, pp. 71-97.
16. Woolfson RG, Hilton PJ, Poston L: Effects of ouabain and low sodium on contractility of human resistance arteries. Hypertension 1990;15:583-590.
17. Kojima I, Yoshihara S, Ogata E: Involvement of endogenous digitalis-like substance in genesis of deoxycorticosterone-salt hypertension. Life Sci 1982;30: 1775-1781.
18. Huang CT, Smith RM: Lowering of blood pressure in chronic aortic coarctate hypertensive rats with anti-digoxin antiserum. Life Sci 1984;35:115-118.
19. Zidek W, Ottens E, Heckmann U: Transmission of hypertension in rats by cross circulation. Hypertension 1989;14:61-65.
20. Mann J FE, Miemietz R, Ganten U, Ritz E: Haemodynamic effects of intact digoxin antibody and its Fab fragments in experimental hypertension. J Hypertens 1987;5:543-549.
21. Krep H, Price DA, Soszynski P, et al: Volume sensitive hypertension and the digoxin-like factor: reversal by a Fab directed against digoxin in DOCA-salt rats. Am J Hypertens 1995;8:921-927.